Anti-Nerve Growth Factor Antibodies Reduce OA Pain, But Associated With Long-Term Adverse Events
Researchers aimed to synthesize the currently available literature on anti-NGF antibodies in OA pain and further determine whether these antibodies are associated with more change in scores for pain and physical function, patient global assessment scores, and AE incidence.